Loading organizations...
Swissortholab operates a specialized dental laboratory, alongside engaging in the comprehensive research, development, manufacturing, and distribution of medical technology products. The company is dedicated to creating advanced devices and solutions pertinent to the medical field, with a particular emphasis on dental applications. Their technical approach integrates practical laboratory services with innovative product design and production.
The company was founded on July 2, 2020, by Luca Signorelli and Caroline Signorelli. Emerging from a recognition of advancements and needs within the dental and broader medical technology sectors, their insight led to establishing an entity capable of both specialized service delivery and product innovation. Luca Signorelli serves as the Chair, with Caroline Signorelli also holding a board position, demonstrating their leadership from the outset.
Swissortholab’s products and services primarily cater to dental practices and medical professionals seeking precision laboratory work and sophisticated medical devices. The company's long-term vision is to consistently push the boundaries of medical technology, delivering solutions that improve patient outcomes and support the rigorous demands of contemporary healthcare environments. They aim to remain a vital contributor to medical innovation.
Swissortholab has 1 tracked investment across 1 company. The latest tracked deal is $2.6M metal - Seed in a-metal in September 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 30, 2025 | a-metal | $2.6M metal - Seed | Basel Sbeini, CFA | Cadfem, Kickfund, Zürcher Kantonalbank |